Cascadion™ SM Immunosuppressants Panel Control 3
Let the assistant research this device
The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.
Free to try · every answer cites its records
Basic Information
- Primary DI
- D-1001877566
- Basic UDI-DI Code
- B-1001877566
- Reference
- 10018775
- Device Types
- None provided
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- No Longer On The Market
- Manufacturer
- Thermo Fisher Scientific Oy
Additional Description
Intended use: The Cascadion™ SM Immunosuppressants Panel is for the quantitative determination of cyclosporine A, tacrolimus, sirolimus, and everolimus in human whole blood by a single injection on the Cascadion™ SM Clinical Analyzer. This liquid-chromatography - tandem mass spectrometry (LCMS/MS) assay is to be used as an aid in the management of transplant patients receiving therapies with these drugs. This in vitro diagnostic device is intended for clinical laboratory use only. The Cascadion™ SM Immunosuppressants Panel Controls are for quality control of the Cascadion SM Immunosuppressants Panel Assay on the Cascadion SM Clinical Analyzer.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W0101050299 | SPECIFIC CONTROLS (CC) - OTHER |
Available In Countries
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).